Objectives
1.Review the history of the pneumococcal organism
2.Present the data on pneumococcal resistance to penicillin and ceftriaxone/cefotaxime over time and in relationship to vaccine use
3.Discuss as a section our collective thoughts about the use of vanco for presumptive therapy of bacterial meningitis
Session date:
02/25/2019 - 12:00pm to 1:00pm CST
Location:
UCMC C-400
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Daniel Johnson, MD